DTIL
$11.51
Revenue | $7.04Mn |
Net Profits | $-16.29Mn |
Net Profit Margins | -231.44% |
Precision Biosciences Inc’s revenue fell -33.59% since last year same period to $7.04Mn in the Q4 2023. On a quarterly growth basis, Precision Biosciences Inc has generated -46.36% fall in its revenue since last 3-months.
Precision Biosciences Inc’s net profit jumped 55.36% since last year same period to $-16.29Mn in the Q4 2023. On a quarterly growth basis, Precision Biosciences Inc has generated -101.62% fall in its net profits since last 3-months.
Precision Biosciences Inc’s net profit margin jumped 32.77% since last year same period to -231.44% in the Q4 2023. On a quarterly growth basis, Precision Biosciences Inc has generated -275.86% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -1.9 |
EPS Estimate Current Year | -1.9 |
Precision Biosciences Inc’s earning per share (EPS) estimates for the current quarter stand at -1.9 - a 7.32% jump from last quarter’s estimates.
Precision Biosciences Inc’s earning per share (EPS) estimates for the current year stand at -1.9.
Earning Per Share (EPS) | -4.06 |
Precision Biosciences Inc’s earning per share (EPS) fell -1461.54% since last year same period to -4.06 in the Q4 2023. This indicates that the Precision Biosciences Inc has generated -1461.54% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-05-09 | -0.23 | -0.23 | 0% |
2023-08-04 | -0.24 | -0.1 | 58.33% |
2023-11-07 | -0.16 | -0.07 | 56.25% |
2024-03-27 | -2.05 | -4.06 | -98.05% |